Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-10-17

FDA Approved: BUDESONIDE — Supplemental Application (Padagis US LLC)

View source ↗

Summary

FDA approved a supplemental application for Budesonide submitted by Padagis US LLC, expanding regulatory authorization for the product. The approval could relat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide (BUDESONIDE)

Snippet

SUPPL AP for BUDESONIDE (BUDESONIDE)